Stockreport

Elite Pharmaceuticals receives FDA approval on its NDA for ADHD treatment [Seeking Alpha]

Elite Pharmaceuticals, Inc.  (ELTP) 
NASDAQ:AMEX Investor Relations: ir.elitepharma.com
PDF version of Vyvanse with strengths of 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg and 70 mg capsules. The product is indicated for the treatment of Attention Deficit Hyper [Read more]